The portfolio of Royalty Pharma Plc (NASDAQ:RPRX) comprises royalties in more than 35 marketed drugs, such as Pfizer’s Nurtec ODT, Novartis ... and royalties on AD medication.

We recently published a list of 8 Most Undervalued Healthcare Stocks to Buy According to Analysts. In this article, we are ...

Nurtec ODT may take 1 to 2 hours to relieve migraine symptoms such as headache, nausea, and photophobia. As a preventive treatment, it may reduce migraine frequency when used consistently over ...

Its not known whether Nurtec ODT (rimegepant) is safe to take while pregnant or breastfeeding. Certain factors, including the risks of not treating your condition during pregnancy, may determine ...

Pfizer's growth is boosted by Nurtec ODT, acquired from Biohaven and Padcev from the Seagen acquisition. By 2030, Pfizer aims to add $25 billion to its top line. Pfizer has already boosted its ...

The Department of Justice (DoJ) claims that Biohaven – before being acquired by Pfizer – paid "improper remuneration" to some Nurtec ODT (rimegepant) prescribers in the form of speaker fees ...

Some drugmakers have achieved success taking this approach. Biohaven Pharmaceuticals launched a campaign on TikTok for migraine medication Nurtec ODT in 2021. The first TikTok the brand posted was an ...

Although the company will lose patent exclusivity for several top drugs, it also has newer products on the market, such as cancer therapies Adcetris and Padcev along with migraine drug Nurtec ODT ...

After learning doctors weren’t prescrbing its migraine drug Nurtec because they assumed insurance coverage would be a hassle, the company created a phone line for doctors and patients to call ...

Zacks Equity Research shares Broadcom AVGO, as the Bull of the Day and Crown Castle CCI as the Bear of the Day. In additi ...

Pfizer had a problem. Doctors weren’t prescribing its migraine drug Nurtec because they assumed insurance coverage would be too much of a hassle. So last year the company created a phone line ...